SCHEMBL30622366

SCHEMBL30622366

C=CC(=O)N1CCn2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]ccc34)c2C1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 7/20 0.46
▸ CSNK1D P48730 4/20 0.46
▸ MAPK11 Q15759 1/20 0.46
▸ JAK3 P52333 9/20 0.39
▸ EGFR P00533 2/20 0.38
▸ JAK1 P23458 1/20 0.38
▸ TEC P42680 1/20 0.38
▸ TXK P42681 1/20 0.38
▸ BLK P51451 1/20 0.38
▸ BMX P51813 1/20 0.38
▸ BTK Q06187 1/20 0.38
▸ ITK Q08881 1/20 0.38
▸ ERBB4 Q15303 1/20 0.38
▸ RPS6KA3 P51812 1/20 0.36
▸ AURKA O14965 2/20 0.36
▸ AURKB Q96GD4 2/20 0.36
▸ IKBKB O14920 1/20 0.36
▸ CHUK O15111 1/20 0.36
▸ LYN P07948 1/20 0.36
▸ IGF1R P08069 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26645123 1.00 MAPK14 (0.46) MAPK14CSNK1DMAPK11JAK3EGFR
SCHEMBL30622417 0.91 BRAF (0.40) MAPK14CSNK1DMAPK11JAK3JAK1
SCHEMBL26644987 0.91 BRAF (0.40) MAPK14CSNK1DMAPK11JAK3JAK1
SCHEMBL30622344 0.87 MAPK14 (0.42) MAPK14CSNK1DMAPK11JAK3EGFR
SCHEMBL26645246 0.87 MAPK14 (0.42) MAPK14CSNK1DMAPK11JAK3EGFR
SCHEMBL30622306 0.87 MAPK14 (0.42) MAPK14CSNK1DMAPK11JAK3EGFR
SCHEMBL26645464 0.87 MAPK14 (0.42) MAPK14CSNK1DMAPK11JAK3EGFR
SCHEMBL30622975 0.85 MAPK14 (0.44) MAPK14CSNK1DMAPK11JAK3EGFR
SCHEMBL30622393 0.85 JAK3 (0.41) MAPK14JAK3EGFRBMXBTK
SCHEMBL26644972 0.85 JAK3 (0.41) MAPK14JAK3EGFRBMXBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 — — EP claimed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO claimed
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 — — EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback